Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q4 2024 vs. Q3 2024
How the institutions holding Sunshine Biopharma Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 10 | 12 | +2 |
| Shares | 35.0K | 20.6K | −14.4K (−41.2%) |
| Value | $111.3K | $61.8K | −$49.5K (−44.5%) |
New holders (4)
Institutions that held Sunshine Biopharma Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connective Capital Management, LLC | 11,345 | $34.0K | 0.04% |
| UBS Group AG | 868 | $2.60K | 0.00% |
| SBI Securities Co., Ltd. | 709 | $2.13K | 0.00% |
| Northwestern Mutual Wealth Management Co | 4 | $12 | 0.00% |
Sold out (2)
Institutions that held Sunshine Biopharma Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Nordwand Advisors, LLC | 500 | $1.59K |
| Jaffetilchin Investment Partners, LLC | 1 | $3 |